11 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 11 of 11 clinical reviews.
A structured clinical protocol for using Egrifta (Tesamorelin) in ACL and ligament rehabilitation, covering dosing, cycle length, monitoring labs, expected outcomes, and the best available evidence.
A physician-reviewed protocol covering dose, timing, cycling, monitoring labs, and stack combinations for Egrifta (Tesamorelin) in longevity and biohacking contexts. Evidence graded by study type.
A structured clinical protocol for using tesamorelin (Egrifta) in recalcitrant Achilles, patellar, and rotator-cuff tendinopathy, including dose, route, cycle length, monitoring labs, and the evidence behind each recommendation.
A physician-reviewed protocol covering dose, timing, cycle length, monitoring labs, and expected outcomes for using tesamorelin to support recovery from CrossFit and high-volume mixed-modal training.
A structured clinical protocol for using tesamorelin (Egrifta) in endurance athletes: dosing, injection timing, cycle length, monitoring labs, and evidence-graded expected outcomes for runners, cyclists, and triathletes.
A physician-reviewed protocol for using Egrifta (tesamorelin) in executive longevity stacks, covering dosing, cycling, monitoring labs, expected timelines, and the strongest available clinical evidence.
A complete clinical protocol for using Egrifta (Tesamorelin) to address age-related sarcopenia in older adults, including dosing, monitoring labs, expected timelines, and the strongest available RCT evidence.
A physician-reviewed protocol for using Egrifta (Tesamorelin) in MMA and combat sports: doses, injection timing, cycle length, monitoring labs, and the clinical evidence behind impact recovery and soft-tissue repair.
A clinician-reviewed protocol covering tesamorelin dosing, timing, cycle length, monitoring labs, and expected outcomes for perimenopausal women managing body composition, sleep, and recovery.
A structured clinical protocol for using tesamorelin (Egrifta) in post-COVID and long-COVID recovery, covering dosing, monitoring labs, expected timelines, and the evidence behind each recommendation.
A clinician-reviewed protocol covering dose, route, frequency, cycle length, monitoring labs, and expected recovery timelines for using tesamorelin after surgery, with primary-source citations.